108 related articles for article (PubMed ID: 9818004)
1. Heterogeneous distribution of macrophages, tumour necrosis factor alpha, tissue factor and fibrinolytic regulators in atherosclerotic vessels.
Falkenberg M; Björnheden T; Odén A; Risberg B
Eur J Vasc Endovasc Surg; 1998 Oct; 16(4):276-83. PubMed ID: 9818004
[TBL] [Abstract][Full Text] [Related]
2. Localization of fibrinolytic activators and inhibitors in normal and atherosclerotic vessels.
Falkenberg M; Tjärnström J; Ortenwall P; Olausson M; Risberg B
Thromb Haemost; 1996 Jun; 75(6):933-8. PubMed ID: 8822589
[TBL] [Abstract][Full Text] [Related]
3. Urokinase plasminogen activator colocalizes with CD25+ cells in atherosclerotic vessels.
Falkenberg M; Giglio D; Björnheden T; Nygren H; Risberg B
J Vasc Res; 1998; 35(5):318-24. PubMed ID: 9789112
[TBL] [Abstract][Full Text] [Related]
4. Co-localization of fibrinolytic activators and inhibitors with macrophages in atherosclerotic vessels.
Falkenberg M; Björnheden T; Lindnér P; Risberg B
Cardiovasc Pathol; 1998; 7(4):223-31. PubMed ID: 25851398
[TBL] [Abstract][Full Text] [Related]
5. Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease.
Padró T; Emeis JJ; Steins M; Schmid KW; Kienast J
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):893-902. PubMed ID: 7600121
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explants.
Padró T; Steins M; Li CX; Mesters RM; Hammel D; Scheld HH; Kienast J
Cardiovasc Res; 1997 Oct; 36(1):28-36. PubMed ID: 9415269
[TBL] [Abstract][Full Text] [Related]
7. Urokinase, tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in severely stenosed and occluded vein grafts with thrombosis.
Sirén V; Kauhanen P; Carpén O; Luther M; Lepäntalo M; Vaheri A; Lassila R
Blood Coagul Fibrinolysis; 2003 Jun; 14(4):369-77. PubMed ID: 12945879
[TBL] [Abstract][Full Text] [Related]
8. Inflammation of the atherosclerotic cap and shoulder of the plaque is a common and locally observed feature in unruptured plaques of femoral and coronary arteries.
Pasterkamp G; Schoneveld AH; van der Wal AC; Hijnen DJ; van Wolveren WJ; Plomp S; Teepen HL; Borst C
Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):54-8. PubMed ID: 9888866
[TBL] [Abstract][Full Text] [Related]
9. Expression of fibrinolytic antigens in redistributed cardiac mast cells in auricular thrombosis.
Bankl HC; Radaszkiewicz T; Pikula B; Baghestanian M; Mehrabi MR; Bankl H; Lechner K; Valent P
Hum Pathol; 1997 Nov; 28(11):1283-90. PubMed ID: 9385934
[TBL] [Abstract][Full Text] [Related]
10. Vascular wall hypoxia promotes arterial thrombus formation via augmentation of vascular thrombogenicity.
Matsuura Y; Yamashita A; Iwakiri T; Sugita C; Okuyama N; Kitamura K; Asada Y
Thromb Haemost; 2015 Jul; 114(1):158-72. PubMed ID: 25833755
[TBL] [Abstract][Full Text] [Related]
11. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.
Fibbi G; D'Alessio S; Pucci M; Cerletti M; Del Rosso M
Biol Chem; 2002 Jan; 383(1):127-36. PubMed ID: 11928807
[TBL] [Abstract][Full Text] [Related]
12. Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis.
Weinberg JB; Pippen AM; Greenberg CS
Arthritis Rheum; 1991 Aug; 34(8):996-1005. PubMed ID: 1677574
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis.
Rus HG; Niculescu F; Vlaicu R
Atherosclerosis; 1991 Aug; 89(2-3):247-54. PubMed ID: 1793452
[TBL] [Abstract][Full Text] [Related]
14. Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells.
Tipping PG; Davenport P; Gallicchio M; Filonzi EL; Apostolopoulos J; Wojta J
Am J Pathol; 1993 Sep; 143(3):875-85. PubMed ID: 8362983
[TBL] [Abstract][Full Text] [Related]
15. Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence.
Sobel BE; Woodcock-Mitchell J; Schneider DJ; Holt RE; Marutsuka K; Gold H
Circulation; 1998 Jun; 97(22):2213-21. PubMed ID: 9631870
[TBL] [Abstract][Full Text] [Related]
16. The plasminogen activator/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings.
Friess H; Duarte R; Kleeff J; Fukuda A; Tang WH; Graber H; Schilling M; Zimmermann A; Korc M; Büchler MW
Surgery; 1998 Jul; 124(1):79-86. PubMed ID: 9663255
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis.
Grandaliano G; Gesualdo L; Ranieri E; Monno R; Schena FP
Am J Kidney Dis; 2000 Apr; 35(4):726-38. PubMed ID: 10739796
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 in neointima of vein grafts: its role in reduced fibrinolytic potential and graft failure.
Kauhanen P; Sirén V; Carpén O; Vaheri A; Lepäntalo M; Lassila R
Circulation; 1997 Sep; 96(6):1783-9. PubMed ID: 9323062
[TBL] [Abstract][Full Text] [Related]
19. Antigen levels of urokinase plasminogen activator and its receptor at the tumor-host interface of colorectal adenocarcinomas are related to tumor aggressiveness.
Buø L; Meling GI; Karlsrud TS; Johansen HT; Aasen AO
Hum Pathol; 1995 Oct; 26(10):1133-8. PubMed ID: 7557947
[TBL] [Abstract][Full Text] [Related]
20. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy.
Lundgren CH; Sawa H; Sobel BE; Fujii S
Circulation; 1994 Oct; 90(4):1927-34. PubMed ID: 7923681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
